Sjögren's disease: open trials in China

30 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07901764
MYTP01 for Immune-Mediated Diseases
Trial Treatment · Zhejiang Provincial People's Hospital
Zhejiang Provincial People's Hospital, Hangzhou
Registry updated 2026-11-04
NCT07732309
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Trial Treatment · Phase 1 · Antengene Biologics Limited
Peking University People's Hospital, Beijing · The First Affiliated Hospital of Bengbu Medical University, Bengbu · Xiangya Hospital of Central South University, Changsha · the First Affiliated Hospital of Sun Yat-sen University, Guangzhou · Sun Yat-sen Memorial Hospital, Sun Yat-sen Universit, Guangzhou · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · Nanfang Hospital of Southern Medical Universit, Guangzhou · The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of University of Science and Technology of China, Hefei · Qilu Hospital of Shandong University, Jinan · Linyi People's Hospital, Linyi · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing · Huashan Hospital Affiliated to Fudan University, Shanghai · Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai · Nuclear Industry General Hospital, Suzhou · The First Hospital of Shanxi Medical University, Taiyuan · Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan · The First Affiliated hospital of Xiamen University, Xiamen · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Registry updated 2026-10-28
NCT07737743
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Beijing · Hefei · Taiyuan
Registry updated 2026-10-28
NCT06379646
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Trial Treatment · China Immunotech (Beijing) Biotechnology Co., Ltd.
Shanghai Changzheng Hospital, Shanghai
Registry updated 2026-10-22
NCT07413341
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Therorna
Shanghai Changzheng Hospital, Shanghai
Registry updated 2026-10-19
NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Beijing
Registry updated 2026-10-13
NCT07843381
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
Research · Peking University People's Hospital
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing
Registry updated 2026-09-28
NCT07301164
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
Trial Treatment · Early phase 1 · Peking University Third Hospital
Peking University Third Hospital, Beijing
Registry updated 2026-09-23
NCT07836660
A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's Disease
Trial Treatment · Phase 2 · Innovent Biologics (Suzhou) Co. Ltd.
The First Affiliated Hospital of University of Science and Technology of China, Hefei
Registry updated 2026-09-23
NCT06828042
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Trial Treatment · Phase 1/2 · Peking University Third Hospital
Peking University Third Hospital, Beijing
Registry updated 2026-09-22
NCT07596680
CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases
Trial Treatment · Early phase 1 · Nanjing Bioheng Biotech Co., Ltd.
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-07-16
NCT07526350
MTS109 in Patients With Refractory Autoimmune Diseases
Trial Treatment · Early phase 1 · Shanghai Changzheng Hospital
Shanghai Changzheng Hospital, Shanghai
Registry updated 2026-06-30
NCT07642843
CM336 for Active Sjogren's Syndrome Study
Trial Treatment · Phase 1 · Keymed Biosciences Co.Ltd
Peking Union Medical College Hospital, Beijing
Registry updated 2026-06-12
NCT06548607
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Trial Treatment · Early phase 1 · Nanjing Bioheng Biotech Co., Ltd.
The Third The People's Hospital Of Bengbu, Bengbu
Registry updated 2026-03-06
NCT07236762
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Trial Treatment · Phase 1 · China Immunotech (Beijing) Biotechnology Co., Ltd.
The third people's Hospital of Bengbu, Bengbu
Registry updated 2026-03-04
NCT06947473
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Trial Treatment · Phase 1/2 · Beijing GoBroad Hospital
Beijing GoBroad Hospital, Beijing
Registry updated 2026-03-03
NCT07236801
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Trial Treatment · Phase 1 · China Immunotech (Beijing) Biotechnology Co., Ltd.
The affiliated hospital of xuzhou medical university, Xuzhou
Registry updated 2026-03-02
NCT07439029
YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Children's Hospital of Fudan University
Children's Hospital Of Fudan University, Shanghai
Registry updated 2026-02-27
NCT07212322
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Trial Treatment · Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, Tianjin
Registry updated 2025-12-19
NCT07062523
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Trial Treatment · Phase 1/2 · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2025-12-01
NCT07145060
A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome
Trial Treatment · China-Japan Friendship Hospital
China-Japan Friendship Hospital, Beijing
Registry updated 2025-08-28
NCT06967038
Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
Trial Treatment · Phase 1/2 · Bangdong Gong
Tongji Hospital of Tongji University, Shanghai
Registry updated 2025-05-13
NCT06794008
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Trial Treatment · Phase 2 · Peking University People's Hospital
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing
Registry updated 2025-04-02
NCT05859997
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
Trial Treatment · Bioray Laboratories
Shanghai Changzheng Hospital, Shanghai
Registry updated 2024-11-20
NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Trial Treatment · Phase 1/2 · Essen Biotech
District One Hospital, Beijing
Registry updated 2024-11-05

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error